Dew, there appears to have been a mistake as I don't see any of my small-cap biotech holdings on your list. Please update your list to correct this oversight. T.i.a. ; )
Regulators in Europe have concluded that there was little evidence that widely used drugs to treat Type 2 diabetes could cause pancreatic inflammation or pancreatic cancer, a finding that might reassure patients while also removing a potential sales threat for Merck and some other drug companies.
“Presently available data do not confirm recent concerns over an increased risk of pancreatic adverse events with these medicines,” the European Medicines Agency said in a news release on Friday.
Although there are several approved DPP-4 drugs, MRK’s Januvia/Janumet franchise has about 2/3 of the worldwide market.
Vaccines for swine have high growth potential as China is the world’s leading pork producing nation, with an annual population of more than 685 million pigs in 2012[The word “population” is not what was meant, IMO.] The joint venture provides a strategic platform for growth in China where the animal health industry is valued at $1.8 billion and is expected to grow at 9.3 percent year over year in the next 5 years.